Page last updated: 2024-10-27

fenofibrate and Insulinoma

fenofibrate has been researched along with Insulinoma in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate has been reported to regulate lipid homeostasis and is involved in insulin secretion in pancreatic beta-cells."1.35Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate. ( Gao, GQ; Gao, L; Gong, B; Guo, H; Ren, M; Sun, Y; Xin, W; Zhang, XJ; Zhao, JJ, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, Y1
Ren, M1
Gao, GQ1
Gong, B1
Xin, W1
Guo, H1
Zhang, XJ1
Gao, L1
Zhao, JJ1

Other Studies

1 other study available for fenofibrate and Insulinoma

ArticleYear
Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate.
    Acta pharmacologica Sinica, 2008, Volume: 29, Issue:4

    Topics: AMP-Activated Protein Kinases; Animals; Cell Culture Techniques; Cell Line, Tumor; Cells, Cultured;

2008